{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:00:48Z","timestamp":1790359248091,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Allergy Immunology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) is uncommon in pediatric populations but may significantly impair quality of life. Adult data support biologics targeting type 2 inflammatory pathways, whereas pediatric evidence remains sparse and largely indirect. This systematic review aimed to summarize the available evidence on both efficacy and safety, rather than to estimate a precise treatment effect. A systematic review was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Scopus, and Cochrane Library databases were searched from inception to March 2026 for studies investigating biologics in pediatric CRSwNP or pediatric type 2 airway disease with CRSwNP\u2010related sinonasal outcomes. Studies focused on cystic fibrosis\u2010associated nasal polyposis or allergic fungal rhinosinusitis (AFRS) were excluded from the primary synthesis and retained only for sensitivity\/contextual analyses. Risk of bias was assessed using design\u2010appropriate tools. Of 404 identified records, six studies were eligible for qualitative review. Four studies (three case series and one retrospective observational study) were retained in the primary synthesis after exclusion of cystic fibrosis\u2010associated nasal polyposis and AFRS; two studies were considered in sensitivity analyses. The available evidence was predominantly low\u2010level, heterogeneous, and based on small samples. Dupilumab, omalizumab, and mepolizumab showed signals of potential benefit in selected type 2 inflammatory phenotypes, but sinonasal outcomes were inconsistently reported. No major treatment\u2010related safety issues were reported, although adverse\u2010event reporting was inconsistent, and follow\u2010up duration was limited and variable. For dupilumab, pediatric CRSwNP\u2010specific safety data remain sparse, and known adverse events described in broader prescribing information, including injection\u2010site reactions, eosinophilia, conjunctivitis, skin reactions, and arthralgia, require active monitoring. Biologics may represent a promising steroid\u2010sparing option for selected pediatric patients with refractory type 2 inflammatory CRSwNP. However, current evidence is predominantly based on case series and indirect cohorts; therefore, conclusions should be considered cautious and hypothesis\u2010generating. Prospective pediatric studies with standardized sinonasal outcomes and longer follow\u2010up are required.<\/jats:p>","DOI":"10.1111\/pai.70451","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:33:03Z","timestamp":1789561983000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biologics in pediatric chronic rhinosinusitis with nasal polyps: A systematic review of efficacy and safety"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-8126","authenticated-orcid":false,"given":"Antonella","family":"Loperfido","sequence":"first","affiliation":[{"name":"Otolaryngology Unit San Camillo Forlanini Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-7651","authenticated-orcid":false,"given":"Roberta","family":"Anzivino","sequence":"additional","affiliation":[{"name":"Otolaryngology Unit, Sensorineural Department Di Venere Hospital  Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-4596","authenticated-orcid":false,"given":"Cosimo","family":"Galletti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Surgery Kore University of Enna  Enna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moffa","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Campus Bio\u2010Medico di Roma, School of Medicine, Fondazione Policlinico Universit\u00e0 Campus Bio\u2010Medico, Integrated Therapies in Otolaryngology  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8555-045X","authenticated-orcid":false,"given":"Davide","family":"Stivalini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Section of Otorhinolaryngology, Santa Maria Della Misericordia Hospital University of Perugia  Perugia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"La Mantia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Surgery Kore University of Enna  Enna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-7018","authenticated-orcid":false,"given":"Eugenio","family":"De Corso","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Section of Otorhinolaryngology, Santa Maria Della Misericordia Hospital University of Perugia  Perugia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S290424"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000778"},{"issue":"29","key":"e_1_2_11_4_1","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens WJ","year":"2020","journal-title":"Rhinology"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7020027"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00576-2021"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.020"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2024.104597"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4027701"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.70032"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.717"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15857"},{"issue":"11","key":"e_1_2_11_13_1","article-title":"Nasal polyps in children: the early origins of a challenging adulthood condition","volume":"8","author":"Cicco ME","year":"2021","journal-title":"Children (Basel)"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000514262"},{"issue":"42","key":"e_1_2_11_15_1","first-page":"703","article-title":"The efficacy and evidence\u2010based use of biologics in children and adolescents: using monoclonal antibodies and fusion proteins as treatments","volume":"116","author":"Niehues T","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anorl.2023.06.006"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-019-0369-7"},{"issue":"4","key":"e_1_2_11_18_1","first-page":"38","article-title":"Biologic therapies targeting Type\u20102 inflammation in pediatric chronic rhinosinusitis: evidence, extrapolation from adults, and a pediatric research agenda","volume":"39","author":"Gori A","year":"2025","journal-title":"Ital J Pediatr Allergy Immunol"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_11_20_1","unstructured":"U.S. Food and Drug Administration.FDA approves drug for adult and pediatric patients aged 6 and older with allergic fungal rhinosinusitis.2026."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.016"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0602-5"},{"issue":"8","key":"e_1_2_11_25_1","article-title":"Mepolizumab in severe pediatric asthma: certainties and doubts through a single\u2010center experience and review of the literature","volume":"11","author":"Maglione M","year":"2024","journal-title":"Children (Basel)"},{"issue":"3","key":"e_1_2_11_26_1","article-title":"Safety of biological therapy in children and adolescents with severe asthma during the COVID\u201019 pandemic: a case series","volume":"93","author":"Votto M","year":"2022","journal-title":"Acta Biomed"},{"key":"e_1_2_11_27_1","volume-title":"DUPIXENT (dupilumab) injection, for subcutaneous use: prescribing information","author":"Sanofi\u2010Aventis U.S. LLC","year":"2026"},{"key":"e_1_2_11_28_1","volume-title":"NUCALA (mepolizumab) for injection, for subcutaneous use: prescribing information","author":"GlaxoSmithKline","year":"2025"},{"key":"e_1_2_11_29_1","volume-title":"XOLAIR (omalizumab) injection, for subcutaneous use: prescribing information","author":"Genentech USA, Inc","year":"2026"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.47162\/RJME.64.2.14"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.12.946"},{"issue":"2","key":"e_1_2_11_32_1","first-page":"140","article-title":"Biologics in children with allergic diseases","volume":"16","author":"Licari A","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.12932\/AP-151025-2164"},{"issue":"7","key":"e_1_2_11_34_1","article-title":"An updated reappraisal of dupilumab in children and adolescents with severe asthma","volume":"11","author":"Marseglia GL","year":"2024","journal-title":"Children (Basel)"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24508"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.963610"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106567"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00558-2023"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.24911\/SJP.106-1544873451"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.05.026"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-015-0150-4"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312282"}],"container-title":["Pediatric Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.70451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pai.70451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.70451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:32:41Z","timestamp":1790357561000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pai.70451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/pai.70451"],"URL":"https:\/\/doi.org\/10.1111\/pai.70451","archive":["Portico"],"relation":{},"ISSN":["0905-6157","1399-3038"],"issn-type":[{"value":"0905-6157","type":"print"},{"value":"1399-3038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70451"}}